Losing Weight May Reduce Your Risk of Breast Cancer
Excess body weight is an established risk factor for breast cancer. Research suggests that’s because too much body fat can elevate levels of sex hormones like estrogen, especially among postmenopausal women. But despite knowing there is a correlation between extra weight and breast cancer, it’s been difficult to study how losing that weight could affect an individual woman’s chance of developing cancer.
Now, a new paper published in the Journal of the National Cancer Institute provides encouraging evidence that, for women 50 and older, virtually any amount of sustained weight loss translates to a reductio...
Source: TIME: Health - December 17, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer embargoed study Source Type: news
Estrogen hormone therapy may reduce breast cancer risk
A study presented at San Antonio Breast Cancer Symposium suggests that estrogen only hormone therapy for postmenopausal women may reduce the risk of breast cancer, whereas estrogen plus progestin hormone therapy may increase risks.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 17, 2019 Category: Endocrinology Source Type: news
New Data on Menopausal Hormone Therapy
'Remarkable' New Data on Menopausal Hormone Therapy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 16, 2019 Category: General Medicine Source Type: news
' Remarkable' New Data on Menopausal Hormone Therapy'Remarkable' New Data on Menopausal Hormone Therapy
Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a lifetime of increased risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Study Shakes Up Thinking on Hormone Replacement Therapy
FRIDAY, Dec. 13, 2019 -- The ongoing debate about postmenopausal hormone therapy and breast cancer risk may have turned even more muddy: A large, new study suggests that two different types of hormone therapy have opposite effects on women ' s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2019 Category: General Medicine Source Type: news
Targeted therapy drug helps women with aggressive breast cancer live longer
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy significantly improves overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common types of the disease.The findings also show the combination treatment is beneficial at the time of recurrence and should become a first-line option in postmenopausal women with HR+/HER2- advanced breast cancer.The study was published today in the New England Journal of Medicine and presented earlier this year at the European Society for Medical Oncology Congress in...
Source: UCLA Newsroom: Health Sciences - December 11, 2019 Category: Universities & Medical Training Source Type: news
Exercise may help reduce side effects of prostate hormone therapy
Short-term exercise may help reduce the adverse side effects of hormone therapy for patients with prostate cancer, according to a study published in theBritish Journal of Urology International (BJUI).Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 11, 2019 Category: Endocrinology Source Type: news
Reducing the side-effects of prostate hormone therapy with exercise
(University of East Anglia) A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research.The trial aimed to reduce the adverse side-effects of hormone therapy such as weight gain and an increased risk of heart problems. The results show that a three month programme of aerobic and resistance training intervention prevented adverse changes in cardiopulmonary fitness and fatigue (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 9, 2019 Category: Cancer & Oncology Source Type: news
Duke research could advance treatments for prostate cancer
A breakthrough coming out of Duke University has the potential to treat prostate cancer cells that have become impervious to hormone therapy – presenting a wealth of potential therapeutic benefits as researchers press forward. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news
Duke research could advance treatments for prostate cancer
A breakthrough coming out of Duke University has the potential to treat prostate cancer cells that have become impervious to hormone therapy – presenting a wealth of potential therapeutic benefits as researchers press forward. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news
Smoking and alcohol use reduce efficacy of hormone therapy
Lifestyle factors such as alcohol use and smoking alter estradiol levels in women receiving hormone therapy, according to a study presented at the North American Menopause Society Annual Meeting.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 27, 2019 Category: Endocrinology Source Type: news
Alcohol, Smoking Alter Estradiol Levels in Hormone Therapy Alcohol, Smoking Alter Estradiol Levels in Hormone Therapy
Alcohol use and smoking independently and inversely predict estradiol levels in women who are postmenopausal, likely because of their involvement with liver metabolism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 25, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Insulin sensitivity greater in transgender men
Transgender men who have undergone hormone therapy have greater insulin sensitivity, according to a study published inDiabetes Care.Diabetes.co.uk (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 22, 2019 Category: Endocrinology Source Type: news
Combination therapy increases height in girls with central precocious puberty
Girls with central precocious puberty treated with combination gonadotropin-releasing hormone analogues and recombinant growth hormone therapy achieve greater adult height, according to findings published inThe Journal of Clinical Endocrinology& Metabolism.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 22, 2019 Category: Endocrinology Source Type: news
Complementary therapies can do more harm than good when breast cancer becomes visible
(European School of Oncology) Patients with advanced breast cancer that has spread to the skin are likely to cause more harm than good if they use complementary therapies to treat their skin lesions. Professor Maria Jo ã o Cardoso told the Advanced Breast Cancer Fifth International Consensus Conference (ABC5) in Lisbon that there was a long list of herbal products and creams that patients often try, but many of them could delay wound healing and interfere with systemic anti-cancer treatments such as hormone therapy or chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2019 Category: Cancer & Oncology Source Type: news
